Article info

Download PDFPDF
Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis

Authors

  1. Correspondence to Professor Martin K Lotz, Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California 92037, USA; mlotz{at}scripps.edu
View Full Text

Citation

Ohzono H, Hu Y, Nagira K, et al
Targeting FoxO transcription factors with HDAC inhibitors for the treatment of osteoarthritis

Publication history

  • Received July 29, 2021
  • Accepted August 27, 2022
  • First published September 15, 2022.
Online issue publication 
January 23, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.